Primary and secondary outcome variables in the intent to treat analysis
| Outcome variables | Total (n=302) | Treatment groups | |||
|---|---|---|---|---|---|
| Placebo (n=103) | O1 (n=98) | O2 (n=101) | |||
| Death | 43 (14%) | 16 (16%) | 15 (15%) | 12 (12%) | |
| Death ⩽14 days | 17 | 3 | 8 | 6 | |
| Death >14/⩽30 days | 9 | 3 | 3 | 3 | |
| Death >30 days | 17 | 10 | 4 | 3 | |
| Patients with newly developed complications | 220 (73%) | 73 (71%) | 74 (76%) | 73 (72%) | |
| Duration of pain (days)12-150 | 6 (0–209) | 6 (0–209) | 6 (0–105) | 7 (1–156) | |
| Hospital stay (days)12-150 | 21 (0–210) | 21 (2–210) | 21 (0–112) | 22 (2–163) | |
↵12-150 Median values (range).